Markets:

Overview

News

Currencies

International

Treasuries

Abbott Laboratories (NY:ABT)

108.93 +0.44 (+0.41%)

Streaming Delayed Price Updated: 10:15 AM EDT, Mar 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

53 54 Next >

Got $200? 2 Healthcare Stocks to Buy and Hold Forever. ↗

April 11, 2024

These companies provide stability, reliability, and passive income.

Via The Motley Fool

7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape ↗

April 10, 2024

Although the market may be grumbling over certain issues, concerned investors can trust these healthcare stocks to deliver the goods.

Via InvestorPlace

Jim Cramer Was Upset At This Hostile Takeover, But 'They Fixed The Situation. Stock's Been A Horse' ↗

April 09, 2024

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he prefers Abbott Laboratories (NYSE: ABT) over

Via Benzinga

3 Dividend Growth Stocks With Yields Above 3% That You Can Buy and Hold for the Next Decade ↗

April 09, 2024

Income-seeking investors can look forward to steady payout raises from these pharma stocks.

Via The Motley Fool

3 Top Dividend Stocks to Buy in April 2024 ↗

April 06, 2024

Each of these high-quality stocks looks like a buy.

Via The Motley Fool

Analyst Ratings For Abbott Laboratories ↗

April 03, 2024

Via Benzinga

How Is The Market Feeling About Abbott Laboratories? ↗

March 28, 2024

Via Benzinga

Performance Comparison: Abbott Laboratories And Competitors In Health Care Equipment & Supplies Industry ↗

March 27, 2024

Via Benzinga

Top Analyst Reports For T-Mobile US, Abbott Laboratories & Palo Alto Networks ↗

April 06, 2024

Today's Research Daily features new research reports on 16 major stocks, including T-Mobile US, Inc. (TMUS), Abbott Laboratories (ABT) and Palo Alto Networks, Inc. (PANW).

Via Talk Markets

FDA Approves Abbott's Heart Valve Repair Device For Patients At Risk Of Complications/Death During Open-Heart Surgeries ↗

April 02, 2024

FDA approves Abbott Laboratories' TriClip TEER system for treating tricuspid regurgitation. Clip technology offers non-invasive repair, fast recovery, and significant improvement in quality of life....

Via Benzinga

DexCom Stock Gains from GLP-1 Diabetic Users

April 02, 2024

DexCom Inc. (NASDAQ: DXCM) is a leading medical device company in the medical sector that specializes in continuous glucose monitoring (CGM) systems. People

Via MarketBeat

Russell 2000 Index Best And Worst Performing Stocks Of 2024 ↗

April 02, 2024

The Russell 2000 index continued to underperform the Dow Jones and Nasdaq 100 indices in the first quarter of 2024.

Via Talk Markets

Topics Stocks

What the Options Market Tells Us About Abbott Laboratories ↗

March 19, 2024

Via Benzinga

$100 Invested In Abbott Laboratories 10 Years Ago Would Be Worth This Much Today ↗

March 08, 2024

Via Benzinga

Is Abbott Laboratories a Top Dividend Growth Stock to Buy Now? ↗

March 07, 2024

Abbott Laboratories has been growing its dividend at a blistering pace. Is its stock a buy?

Via The Motley Fool

3 Strong Buy Healthcare Stocks to Add to Your Q2 Must-Watch List ↗

March 29, 2024

In an aging world, strong buy healthcare stocks like UNH, ABT, and MRK shine with dividends, innovation, and market growth.

Via InvestorPlace

Winning Over Wall Street: 3 Stocks Earning Overwhelming Analyst Approval ↗

March 26, 2024

Discover the investment potential of three stocks with analyst approval for their robust financials and strategic market positions.

Via InvestorPlace

More Than 86% of Analysts Who Cover These 3 Stocks Rate Them a ‘Buy’ ↗

March 25, 2024

Investors should take notice of these stocks with high analyst ratings. It's time to load up your portfolio.

Via InvestorPlace

Want Decades of Passive Income? 2 Stocks to Buy Now. ↗

March 22, 2024

There aren't many guarantees in the equity market, but the dividend payouts of Johnson & Johnson and Abbott Laboratories may be as close as it gets to a sure thing.

Via The Motley Fool

3 Stocks to Buy Right Now for the Coming Recession ↗

March 21, 2024

With numerous economic indicators souring, these three stocks to buy for a recession will protect your portfolio's downside.

Via InvestorPlace

Topics Economy

3 Resilient Stocks to Protect Your Wealth During a Recession ↗

March 21, 2024

Discover three recession-resistant stocks with growth leads in the consumer staples, household products, and healthcare industries.

Via InvestorPlace

Beyond the Pill: Athletes Champion PEMF and Non-Opioid Solutions for Pain Management (ENDV)

March 20, 2024

Via AB Newswire

Topics Death

What's Going On With Abbott Laboratories Stock On Friday? ↗

March 15, 2024

An Illinois jury orders Reckitt Benckiser's Mead Johnson to pay $60 million after a premature infant's tragic death linked to Enfamil baby formula. Mead Johnson found negligent for not warning about...

Via Benzinga

Topics Lawsuit

Why Abbott's Formula-Related Sell-Off Could Be A Buying Opportunity, Says Analyst ↗

March 15, 2024

Fellow infant formula maker Reckitt Benckiser was ordered to pay $60 million to a mother whose baby died after eating Enfamil.

Via Investor's Business Daily

Topics Death

SCHD ETF Spotlight: The Top 6 Stocks Inside This Dividend Monster ↗

March 13, 2024

With over 100 dividend growth stocks in its portfolio, the SCHD ETF has proved to be a formidable income-generating vehicle for investors.

Via InvestorPlace

Topics ETFs

Medtronic is a Dividend Aristocrat That Keeps Gaining

March 11, 2024

A strong earnings report backed by raised guidance adds to the allure of Medtronic stock, which is already a Dividend Aristocrat in the healthcare sector

Via MarketBeat

3 Dividend Kings of Healthcare Stocks to Buy Hand Over Fist in March ↗

March 11, 2024

These are some of the best-performing stocks in what's arguably society's most important industry.

Via The Motley Fool

Are These 5 Undervalued Stocks Ready to Break Out?

March 08, 2024

Undervalued stocks Albemarle, Ionis, Insulet, Hess and Wynn beat earnings views, offering potential for investors to buy quality companies at discounted prices.

Via MarketBeat

FDA Approval For DexCom's Stelo Opens Continuous Glucose Monitoring To Masses, Analyst Expects Competitive Pricing Against Abbott's ↗

March 06, 2024

FDA greenlights DexCom's Stelo, the first OTC continuous glucose monitor for non-insulin-dependent diabetics. Competitive pricing, potential HSA benefits, and market expansion make it a significant...

Via Benzinga

3 Dividend Aristocrats With the Largest 10-Year Dividend Growth Rates ↗

March 06, 2024

These three dividend stocks have proved themselves to be among the best Dividend Aristocrats to buy for high-growth returns.

Via InvestorPlace

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

53 54 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.